Cytovation is a biotechnology company dedicated to provide innovative products in life science that improve people’s lives. Our lead compound, CyPep-1, is a novel peptide that selectively targets and destroys tumor cells and bacterias. It has proven efficient in reducing tumor growth across a wide array of different cancer types. It has also shown to be able to eradicate drug resistant bacteria within minutes.
Our focus is on skin tumors and infections with a lead compound in preclinical development for cutaneous warts and multiresistant bacterial infections.